Alpha hydroxy acids (AHAs) — glycolic, lactic, and mandelic acid, the exfoliating acids in most "brightening" toners and peels — have far weaker acne evidence than their shelf presence suggests. The largest systematic review of them found the clinical benefit unclear, and the leading US dermatology guideline declines to recommend for or against glycolic acid peels at all. That is not the same as saying AHAs do nothing. It means the research base is thin, mostly small, and rarely designed to show whether an AHA beats the cheaper acne ingredients already sitting next to it on the shelf.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the largest review actually concluded
- Why the AAD won't take a position on glycolic peels
- The strongest positive evidence for a leave-on AHA
- Why the pH on the label matters more than the percentage
- Sun sensitivity, legal limits, and what the label can claim
- How to use this evidence when choosing a product
- Frequently Asked Questions
What the largest review actually concluded
Cochrane, an international group that pools results across trials rather than running its own, published a 2020 review of topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acids for acne. It gathered 49 trials with 3,880 participants. Its verdict on AHAs, reported in the Cochrane review, was that clinical benefit is unclear, with low-certainty evidence throughout. "Low certainty" is a technical rating, and it matters.
It means further research would likely change the estimate — the trials were small, inconsistently designed, or measured outcomes in ways that make pooling unreliable. The one direct AHA comparison inside that review is the most useful detail for a shopper. Cochrane's summary reports no clear difference in Physician's Global Assessment between a glycolic acid peel and a salicylic–mandelic acid peel. AHAs were not shown superior to a cheaper, better-studied alternative.
Why the AAD won't take a position on glycolic peels
The American Academy of Dermatology updated its acne guideline in January 2024. On chemical peels — glycolic acid peels included — along with lasers, light devices and microneedling, the AAD guideline states the evidence is insufficient to make any recommendation for or against them. Read that carefully, because it is easy to misread in both directions.
It is not a safety warning and not a finding that peels fail. It is a statement that nobody has produced trials good enough to score. Practically, this means an in-office glycolic peel for acne is being sold on clinical experience rather than on guideline backing. That may still be reasonable for an individual patient, but it should change how much you are willing to pay and how quickly you expect to judge results.
The strongest positive evidence for a leave-on AHA
Not all of the evidence is negative. A 120-patient double-blind, placebo-controlled randomized trial tested a 10% glycolic acid oil-in-water emulsion in patients aged 12 and over with mild acne. Improvement appeared at 45 days and continued after three months of daily use, as described in a 2023 review in Cosmetics. That design carries weight.
Double-blind means neither patient nor assessor knew who got the active product; placebo-controlled means the comparison accounts for people improving anyway. It is the clearest positive trial for a leave-on AHA rather than a peel. Two limits are worth holding onto. The population was mild acne, not moderate or severe, and the timeline was slow — 45 days before a signal, three months for more. If you try an AHA, judge it on that schedule, not after two weeks.
Why the pH on the label matters more than the percentage
Laboratory work published in *Scientific Reports* found glycolic acid's ability to kill *Cutibacterium acnes*, the bacterium involved in acne lesions, depends on pH. Across a pH 3–4.5 range it was most potent at pH 3, and the 2020 study describes it disrupting the bacterial cell membrane at pH 3.5, with the non-ionized form doing the work. The striking number is the concentration.
Concentrations as low as 0.2% were bactericidal at a suitable pH — against conventional peel use above 20%. If that holds in skin, the pH of a formulation, not the percentage printed on the front, would drive the antibacterial effect. The caveat is large and non-negotiable: this was in vitro, in laboratory conditions, and was not tested on patients. Skin is not a culture dish, and a low-percentage, low-pH product has not been shown to clear acne in a trial.
Sun sensitivity, legal limits, and what the label can claim
The FDA recommends that any topically applied cosmetic containing an AHA carry a "Sunburn Alert" advising sunscreen, protective clothing and limited sun exposure — during use *and for a week afterwards*. The FDA guidance, issued in January 2005, applies at any concentration, so a low-strength product is not exempt. Safe-use limits also differ by market, which explains confusing label variation. The US Cosmetic Ingredient Review Expert Panel deems consumer AHA products safe at 10% or less with a finished pH of 3.5 or higher, per the CIR safety assessment.
The EU's SCCS set glycolic acid at a 4% maximum and pH 3.8 or higher. An identical product can be legal in one market and not the other. There is also a regulatory point that affects what you can expect from a purchase. AHAs are sold as cosmetics, not as FDA-recognized over-the-counter acne drug actives — that status belongs to benzoyl peroxide, salicylic acid, sulfur/resorcinol and adapalene. An AHA product cannot legally make a drug-strength acne claim, and it sits outside the monograph evidence base entirely.
How to use this evidence when choosing a product
The evidence supports a modest, specific role rather than a headline one. Here is what it reasonably justifies: If an AHA is not helping after three months of consistent use, the evidence gives you no reason to escalate the concentration and every reason to move to an ingredient with monograph standing.
- Treat AHAs as an adjunct, not a core acne treatment. The recognized drug actives have the monograph status and the evidence base; AHAs do not.
- If your acne is mild and you want to try one, a leave-on 10% glycolic product matches the one positive placebo-controlled trial more closely than an occasional peel does.
- Give it 45 days before deciding, and three months before concluding it has done all it will.
- Check the pH if the brand publishes it. CIR's limit is 10% at pH 3.5 or higher, and the lab work suggests pH is doing more work than percentage.
- Wear sunscreen daily while using it and for a week after stopping, as the FDA advises — this applies at every strength.
Frequently Asked Questions
Is glycolic acid better than salicylic acid for acne?
Cochrane's 2020 review found no clear difference in Physician's Global Assessment between a glycolic acid peel and a salicylic–mandelic acid peel. Salicylic acid is also a recognized OTC acne drug active, which glycolic acid is not.
Does a higher AHA percentage work better?
Not necessarily. Laboratory work found 0.2% glycolic acid was bactericidal against *C. acnes* at a suitable pH, versus peels used above 20% — but that was in vitro and never tested on patients.
Why does my US product have more glycolic acid than the European version?
The US CIR panel accepts 10% or less at pH 3.5 or higher; the EU's SCCS caps glycolic acid at 4% with pH 3.8 or higher. The same formula can be legal in one market and not the other.